Conexeu Sciences Wishes to Make a Regenerative Breast Matrix Solution (and sell shares)

• Conexeu Sciences wants to commercialize a regenerative breast matrix solution. For years, Australian firm BellaSeno and Lattice Medical have been working on similar solutions. In 2018, Lattice came out with...

Conexeu Sciences wants to commercialize a regenerative breast matrix solution. For years, Australian firm BellaSeno and Lattice Medical have been working on similar solutions. In 2018, Lattice came out with Osteoconductive lattice structures that bioabsorb. BellaSeno started clinical trials in 2022. The company is said to be doing well in those areas and can offer some products in Europe as it opens a European manufacturing facility. Now Conexeu is developing what it calls the B.R.E.A.S.T. platform, short for Bio-Regenerative Ergonomically Architected Smart Tissue. The company says the technology uses 3D printed extracellular matrix (ECM)-based biomaterials designed to support soft tissue regeneration after breast reconstruction procedures. The broader regenerative platform is being devel